Jeffrey M. Lemons

809 total citations · 1 hit paper
8 papers, 523 citations indexed

About

Jeffrey M. Lemons is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, Jeffrey M. Lemons has authored 8 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 2 papers in Pulmonary and Respiratory Medicine and 2 papers in Radiation. Recurrent topics in Jeffrey M. Lemons's work include Cancer Immunotherapy and Biomarkers (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Jeffrey M. Lemons is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). Jeffrey M. Lemons collaborates with scholars based in United States, Switzerland and Japan. Jeffrey M. Lemons's co-authors include Steven J. Chmura, Jason J. Luke, Sean P. Pitroda, Manish Sharma, Linda Janisch, J.M. Melotek, Ainhoa Arina, Yuanyuan Zha, Nikolai N. Khodarev and Paul J. Chang and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Neuro-Oncology.

In The Last Decade

Jeffrey M. Lemons

8 papers receiving 520 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors

2018 434 citations Jason J. Luke, Jeffrey M. Lemons et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey M. Lemons United States	5	408	211	157	83	79	8	523
Nathan Comeaux United States	4	444 1.1×	308 1.5×	134 0.9×	62 0.7×	76 1.0×	9	559
Katherine S. Tzou United States	11	169 0.4×	275 1.3×	73 0.5×	108 1.3×	53 0.7×	42	509
Krikor Bornazyan United States	4	709 1.7×	479 2.3×	189 1.2×	96 1.2×	77 1.0×	7	838
Nergiz Dağoğlu Türkiye	11	244 0.6×	183 0.9×	67 0.4×	63 0.8×	170 2.2×	35	440
Valentina Borzillo Italy	10	352 0.9×	196 0.9×	141 0.9×	139 1.7×	98 1.2×	32	557
Yu Ohkubo Japan	10	177 0.4×	120 0.6×	148 0.9×	77 0.9×	141 1.8×	25	494
Rafael Martìnez Monge Spain	6	176 0.4×	125 0.6×	70 0.4×	61 0.7×	63 0.8×	13	345
Chi‐Chung Tong China	13	271 0.7×	136 0.6×	35 0.2×	55 0.7×	230 2.9×	31	590
Carol Felix United States	10	256 0.6×	196 0.9×	89 0.6×	70 0.8×	160 2.0×	14	557
Jahan Aghalar United States	5	269 0.7×	133 0.6×	98 0.6×	25 0.3×	66 0.8×	9	355

Countries citing papers authored by Jeffrey M. Lemons

Since Specialization

Citations

This map shows the geographic impact of Jeffrey M. Lemons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey M. Lemons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey M. Lemons more than expected).

Fields of papers citing papers by Jeffrey M. Lemons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey M. Lemons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey M. Lemons. The network helps show where Jeffrey M. Lemons may publish in the future.

Co-authorship network of co-authors of Jeffrey M. Lemons

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey M. Lemons. A scholar is included among the top collaborators of Jeffrey M. Lemons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey M. Lemons. Jeffrey M. Lemons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Juloori, Aditya, Rohan Katipally, Jeffrey M. Lemons, et al.. (2022). Phase 1 Randomized Trial of Stereotactic Body Radiation Therapy Followed by Nivolumab plus Ipilimumab or Nivolumab Alone in Advanced/Unresectable Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 115(1). 202–213. 42 indexed citations

2.

Juloori, Aditya, Jeffrey M. Lemons, Anurag K. Singh, et al.. (2020). Phase I Study of Stereotactic Body Radiotherapy followed by Ipilimumab with Nivolumab vs. Nivolumab alone in Unresectable Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 108(3). S149–S150. 4 indexed citations

3.

Luke, Jason J., Jeffrey M. Lemons, Theodore Karrison, et al.. (2018). Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 36(16). 1611–1618. 434 indexed citations breakdown →

4.

Jutzy, Jessica M.S., Jeffrey M. Lemons, Jason J. Luke, & Steven J. Chmura. (2018). The Evolution of Radiation Therapy in Metastatic Breast Cancer: From Local Therapy to Systemic Agent. International Journal of Breast Cancer. 2018. 1–7. 15 indexed citations

5.

Lemons, Jeffrey M., Jason J. Luke, Theodore Karrison, et al.. (2018). Safety and clinical activity of pembrolizumab immunotherapy and multi-organ site ablative stereotactic body radiotherapy (iMOSART) in patients with advanced solid tumors.. Journal of Clinical Oncology. 36(5_suppl). 20–20. 2 indexed citations

6.

Lemons, Jeffrey M., et al.. (2017). The ADscopal Effect? Control of Partially Irradiated Versus Completely Irradiated Tumors on a Prospective Trial of Pembrolizumab and SBRT Per NRG-BR001. International Journal of Radiation Oncology*Biology*Physics. 99(2). S87–S87. 11 indexed citations

7.

MacLennan, Gregory T., et al.. (2016). Anatomical contouring variability in thoracic organs at risk. Medical dosimetry. 41(4). 344–350. 14 indexed citations

8.

Feng, Christine H., Jeffrey M. Lemons, David R. Raleigh, et al.. (2016). RTHP-32. RECONSIDERING RADIORESISTANCE: LINAC-BASED STEREOTACTIC RADIOSURGERY FOR INTRACRANIAL METASTASES FROM MELANOMA AND RENAL CELL CARCINOMA. Neuro-Oncology. 18(suppl_6). vi181–vi181. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact